Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1984 2
1986 3
1987 2
1990 1
1995 1
1996 1
1998 2
1999 1
2000 1
2004 2
2006 1
2007 1
2008 1
2009 1
2010 1
2012 3
2015 1
2016 1
2019 2
2020 2
2021 5
2025 2
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

37 results

Results by year

Filters applied: . Clear all
Page 1
Long-term testosterone pellet insertion in women with low libido shows no evidence of erythrocytosis and a minimal side effect profile.
Hernandez BS, Saffati G, Lowrey KA, Reddy A, Park BS, Song JJ, Lyon G, Khera M. Hernandez BS, et al. Transl Androl Urol. 2025 Jul 30;14(7):1842-1848. doi: 10.21037/tau-2025-51. Epub 2025 Jul 28. Transl Androl Urol. 2025. PMID: 40800100 Free PMC article.
METHODS: A retrospective chart review of female patients who underwent testosterone pellet insertion from 2009 to 2022 was undertaken. Women taking 75 and 100 mg testosterone pellets were identified and analyzed for biochemical and clinical data …
METHODS: A retrospective chart review of female patients who underwent testosterone pellet insertion from 2009 to 2022 was und …
Risks of Testosterone for Postmenopausal Women.
Pinkerton JV, Blackman I, Conner EA, Kaunitz AM. Pinkerton JV, et al. Endocrinol Metab Clin North Am. 2021 Mar;50(1):139-150. doi: 10.1016/j.ecl.2020.10.007. Epub 2021 Jan 11. Endocrinol Metab Clin North Am. 2021. PMID: 33518182 Review.
Transdermal testosterone therapy, dosed within premenopausal physiologic testosterone ranges, used alone or with menopausal hormone therapy for postmenopausal hypoactive sexual desire disorder, has shown short-term efficacy, with few androgenic side effects. …
Transdermal testosterone therapy, dosed within premenopausal physiologic testosterone ranges, used alone or with menopausal ho …
The use of testosterone after menopause.
Davis SR. Davis SR. J Br Menopause Soc. 2004 Jun;10(2):65-9. doi: 10.1258/136218004774202373. J Br Menopause Soc. 2004. PMID: 15207027 Review.
However, long-term safety data for combined-oestrogen testosterone therapy are lacking, and the effects of testosterone-only therapy in postmenopausal women are unknown. ...All women treated with testosterone need to be carefully monitore …
However, long-term safety data for combined-oestrogen testosterone therapy are lacking, and the effects of testosterone …
Effects of subdermal implants of estradiol and testosterone on the endometrium of postmenopausal women.
Filho AM, Barbosa IC, Maia H Jr, Genes CC, Coutinho EM. Filho AM, et al. Gynecol Endocrinol. 2007 Sep;23(9):511-7. doi: 10.1080/09513590701550064. Gynecol Endocrinol. 2007. PMID: 17943546
A retrospective review of the medical records of 258 postmenopausal patients using estradiol and testosterone implants as combined hormone therapy was carried out to evaluate the effects of testosterone on the endometrium after two years of continuous …
A retrospective review of the medical records of 258 postmenopausal patients using estradiol and testosterone implants as comb …
Exogenous androgens in postmenopausal women.
Sands R, Studd J. Sands R, et al. Am J Med. 1995 Jan 16;98(1A):76S-79S. doi: 10.1016/s0002-9343(99)80062-x. Am J Med. 1995. PMID: 7825643 Review.
There is an increasing awareness that androgens are of therapeutic value in postmenopausal women. Evidence is emerging demonstrating the role of testosterone in both female embryologic development and normal sexual behavior and mood. ...Such therapy is underused and …
There is an increasing awareness that androgens are of therapeutic value in postmenopausal women. Evidence is emerging demonstrating …
The effects of low-dose testosterone treatment on lipid metabolism, clotting factors and ultrasonographic ovarian morphology in women.
Buckler HM, McElhone K, Durrington PN, Mackness MI, Ludlam CA, Wu FC. Buckler HM, et al. Clin Endocrinol (Oxf). 1998 Aug;49(2):173-8. doi: 10.1046/j.1365-2265.1998.00525.x. Clin Endocrinol (Oxf). 1998. PMID: 9828903 Clinical Trial.
However, little is known about the long-term safety of androgen use in women. This study investigated the effects of low dose exogenous testosterone (T) on lipid metabolism, markers of activation of the coagulation system and ultrasonographic ovarian morpholo …
However, little is known about the long-term safety of androgen use in women. This study investigated the effects of low dose …
Testosterone Therapy in Women: A Literature Review of Clinical Indications, Dosing, Routes of Administration, and Safety.
Montero Bernaldez J, Burgess ER, Martinez R, Peñalver M. Montero Bernaldez J, et al. Cureus. 2026 Apr 9;18(4):e106713. doi: 10.7759/cureus.106713. eCollection 2026 Apr. Cureus. 2026. PMID: 42110023 Free PMC article. Review.
Testosterone (T) therapy has been used to address symptoms in women such as low libido, fatigue, and mood disturbances. ...Adverse effects are typically mild and reversible, with acne and hirsutism being the most common. ...
Testosterone (T) therapy has been used to address symptoms in women such as low libido, fatigue, and mood disturbances. ... …
A clinical update on female androgen insufficiency--testosterone testing and treatment in women presenting with low sexual desire.
Burger HG, Papalia MA. Burger HG, et al. Sex Health. 2006 May;3(2):73-8. doi: 10.1071/sh05055. Sex Health. 2006. PMID: 16800391 Review.
Adverse effects of testosterone treatment are few if replacement is monitored to achieve physiological circulating testosterone concentrations. Currently, available methods include testosterone implants and testosterone creams, and …
Adverse effects of testosterone treatment are few if replacement is monitored to achieve physiological circulating t …
Androgen therapy in midlife and older women: a position statement of the Latin American Association of Gynecological Endocrinology (ALEG).
Pilnik S, Belardo A, Marchesan LB, Camero-Lascano A, Acuña-San Martín M, Elizalde-Cremonte A, Ojeda E, Manzur A, Chedraui P. Pilnik S, et al. Climacteric. 2025 Oct;28(5):529-536. doi: 10.1080/13697137.2025.2548805. Epub 2025 Sep 8. Climacteric. 2025. PMID: 40919649
Subcutaneous pellets and compounded "bioidentical" Testosterone are not recommended due to risks of supraphysiological dosing and insufficient evidence (Grade C: Low). ...Our recommendations on the indication of Testosterone therapy for postmenopausal wome …
Subcutaneous pellets and compounded "bioidentical" Testosterone are not recommended due to risks of supraphysiological dosing …
A practical guide to prescribing hormone replacement therapy.
McKinney KA, Thompson W. McKinney KA, et al. Drugs. 1998 Jul;56(1):49-57. doi: 10.2165/00003495-199856010-00005. Drugs. 1998. PMID: 9664198 Review.
Progestogen should be added to therapy in women with an intact uterus in a cyclical or continuous regimen. The management of common estrogenic and progestogenic adverse effects is important in improving compliance. ...However, HRT is not without adverse …
Progestogen should be added to therapy in women with an intact uterus in a cyclical or continuous regimen. The management of common e …
37 results